Morten Bøttcher
Morten Bøttcher is an expert in Cardiology at Aarhus University (Denmark). As of October 2026, ScienceLeadR ranks Morten Bøttcher in the top 1% of experts worldwide for Angina Pectoris, Coronary Disease and Arteriosclerosis. Morten Bøttcher has authored 325 publications, the most recent in 2026, and is an investigator in 38 clinical trials, 14 of them ongoing. SLR score: 1,785 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 325
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial. PMID 42747817 — glucagon-like peptide 1, quality of life, safety, cardiovascular diseases, frailty, semaglutide | JAMA Cardiol | 2026 | 0 |
| Response to Ferreira et al. PMID 42692993 | Eur Heart J Cardiovasc Imaging | 2026 | 0 |
| Prevalence of Silent Atherosclerosis across Adult Life. PMID 42670946 — cardiovascular diseases, arteries, prevalence, sex, atherosclerosis | N Engl J Med Top journal | 2026 | 4 |
| Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event. PMID 42670965 — safety, hemorrhage, ischemic stroke, stroke, myocardial infarction, acute coronary syndrome, therapeutics | N Engl J Med Top journal | 2026 | 1 |
| Tipping the balance: impact of class imbalance correction on the performance of clinical risk prediction models. PMID 42533626 — medical informatics applications, medical informatics, probability, learning | J Am Med Inform Assoc | 2026 | 0 |
Clinical Studies 38
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
14 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Research study on how well oral semaglutide works for weight loss in adults with excess body weight 2025-524626-18-00 — safety, body weight, obesity, research, weight loss, overweight, semaglutide | Phase 3 | Recruiting | 2026 |
| A Placebo Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) Whose Current Treatment with Lipid Modifying Therapies is not Sufficiently Effective 2023-507795-51-00 — blood, heart, cardiovascular diseases, arteries, plague, therapeutics, blood vessels, lipids | Phase 3 | Active not recruiting | 2022 |
| A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure 2024-514506-32-00 — heart failure, heart | Phase 3 | Not yet recruiting | 2025 |
| A randomized double blind placebo controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high risk primary prevention patients (VICTORION 1 PREVENT) 2022-502779-40-00 — cardiovascular diseases, primary prevention | Phase 3 | Active not recruiting | 2023 |
| A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High Bad Cholesterol from an Inherited Condition 2025-520520-17-00 — cholesterol, ldl, lipoproteins, cholesterol, lipoproteins, ldl | Phase 3 | Active not recruiting | 2025 |
LeadR Networks
Main global connection map